Microbes tested with blue light disinfection
The below long list of microbes have been tested with blue light disinfection in peer-reviewed research papers. Typically the tests have been done with generic light sources, using one blue wavelength. For results with Spectral Blue MWHI technology, please see the section 'Laboratory tests'.
Search:Microbe | Type | Wave-length [nm] | Median dose / log-level [J/cm2] (article group 1) | Radiant exposure [J/cm2] (article group 2) | % reduction (article group 2) | 90% reduction dose [J/cm2] (article group 3: viruses) | Ref. | Notes |
---|---|---|---|---|---|---|---|---|
Acinetobacter baumannii | Gram-negative bacteria | 400 | 16.7 | Halstead et al. 2016 | ||||
Acinetobacter baumannii | Gram-negative bacteria | 405 | 14.0 | Maclean et al. 2009, Ramakrishnan et al. 2014 | ||||
Acinetobacter baumannii | Gram-negative bacteria | 415 | 17.6 | Zhang et al. 2014 | ||||
Acinetobacter baumannii | Gram-negative bacteria | 405 | 144–270 | 99.99–99.9999% | Leanse et al. 2018, Shehatou et al. 2019, Wozniak et al. 2019 | |||
adenovirus (dsDNA) | non-enveloped viruses | 420 | 29 | Terrosi et al. 2021 | Riboflavin present in test*: yes | |||
Aggregatibacter actinomycetemcomitans | Gram-negative bacteria | 405 | 60 | 49.7% | Al Hamzi et al. 2019 | |||
Aggregatibacter actinomycetem. | Gram-negative bacteria | 460 | 30.0 | Cieplik et al. 2014 | ||||
Aspergillus flavus | Fungi | 405 | 540 | <90% | Leanse et al. 2021 | |||
Aspergillus fumigatus | Fungi | 405 | 540 | <90% | Leanse et al. 2021 | |||
Bacillus atrophaeus | Gram-positive bacteria | 470 | 110.2 | De Lucca et al. 2012 | ||||
Bacillus cereus | Gram-positive bacteria | 405 | 93.5 | Maclean et al. 2013, Kumar et al. 2015 | ||||
Bacillus cereus | Gram-positive bacteria | 405 | 50 | 99.9% | Lu et al. 2020 | |||
Bacillus cereus spores | Gram-positive bacteria | 405 | 542.9 | Maclean et al. 2013 | ||||
Bacillus megaterium spores | Gram-positive bacteria | 405 | 638.9 | Maclean et al. 2013 | ||||
Bacillus subtilis | Gram-positive bacteria | 408 | 69.0 | Hoenes et al. 2015 | ||||
Bacillus subtilis | Gram-positive bacteria | 451 | 100.0 | Hoenes et al. 2015 | ||||
Bacillus subtilis spores | Gram-positive bacteria | 405 | 676.5 | Maclean et al. 2013 | ||||
BCoV (ssRNA, coronavirus) | lipid-enveloped viruses | 401 | 29 | Zavestovskaya et al. 2021 | Riboflavin present in test*: yes | |||
BCoV (ssRNA, coronavirus) | lipid-enveloped viruses | 405 | 57.5-96 | Lau et al. 2021 | Riboflavin present in test*: no | |||
Campylobacter jejuni | Gram-negative bacteria | 405 | 3.4 | Murdoch et al. 2010 | ||||
Campylobacter jejuni | Gram-negative bacteria | 463 | 24 | 99.81% | Meurer et al. 2020 | |||
Campylobacter jejuni | Gram-negative bacteria | 405 | 24 | 81.82% | Meurer et al. 2020 | |||
Candida albicans | Yeasts | 450 | 360 | >80% | Dong et al. 2020 | |||
Candida albicans | Yeasts | 405–415 | 50–108 | >80–99.9999% | Dong et al. 2020, Shehatou et al. 2019, Leanse et al. 2020 | |||
Candida vaginitis | Yeasts | 470 | 360 | 23.44% | Wang et al. 2020 | |||
Candida vaginitis | Yeasts | 405–415 | 225 | >99.9% | Wang et al. 2020 | |||
Chlostridium difficile | Gram-positive bacteria | 405 | 13.0 | Maclean et al. 2013 | ||||
Chlostridium difficile spores | Gram-positive bacteria | 405 | 251.1 | Maclean et al. 2013, Moorhead et al. 2016 | ||||
Clostridium perfringens | Gram-positive bacteria | 405 | 10.2 | Maclean et al. 2009 | ||||
Corynebacterium striatum | Gram-positive bacteria | 405 | 120.6 | McDonald et al. 2013 | ||||
Cronobacter sakazakii | Gram-negative bacteria | 415 | 240 | 99.999999% | Chu et al. 2019 | |||
Elizabethkingia meningoseptica | Gram-negative bacteria | 400 | 8.0 | Halstead et al. 2016 | ||||
encephalomyocarditis virus (ssRNA) | non-enveloped viruses | 405 (blue + white) | 178 | Rathnasinghe et al. 2021 | Riboflavin present in test*: unknown | |||
Enterobacter cloacae complex | Gram-negative bacteria | 400 | 92.3 | Halstead et al. 2016 | ||||
Enterococcus faecalis | Gram-positive bacteria | 405 | 96.0 | Maclean et al. 2009, McDonald et al. 2013, Lui et al. 2016 | ||||
Enterococcus faecalis | Gram-positive bacteria | 430 | 190.0 | Lui et al. 2016 | ||||
Enterococcus faecalis | Gram-positive bacteria | 455 | 410.0 | Lui et al. 2016 | ||||
Enterococcus faecium | Gram-positive bacteria | 400 | 348.4 | Halstead et al. 2016 | ||||
Enterococcus faecium | Gram-positive bacteria | 405 | 540 | 99.99% | Shehatou et al. 2019 | |||
Enterococcus moraviensis | Gram-positive bacteria | 405 | 200 | 90 % | Hessling et al. 2020 | |||
Enterococcus moraviensis | Gram-positive bacteria | 450 | 750 | 90 % | Hessling et al. 2020 | |||
Enterococcus Spp. | Gram-positive bacteria | 405 | 360 | 99.999% | Shehatou et al. 2019 | |||
Escherichia coli | Gram-negative bacteria | 400 | 46.3 | Halstead et al. 2016 | ||||
Escherichia coli | Gram-negative bacteria | 405 | 75.6 | Lui et al. 2016, DH5α, Rhodes et al. 2016 | ||||
Escherichia coli | Gram-negative bacteria | 408 | 156.7 | Hoenes et al. 2015 | ||||
Escherichia coli | Gram-negative bacteria | 415 | 60.0 | Lipovsky et al. 2010 | ||||
Escherichia coli | Gram-negative bacteria | 425 | 56.1 | Kim et al. 2013 | ||||
Escherichia coli | Gram-negative bacteria | 430 | 100.0 | Lui et al. 2016 | ||||
Escherichia coli | Gram-negative bacteria | 445 | 540 | <90% | Halstead et al. 2019 | |||
Escherichia coli | Gram-negative bacteria | 450 | 137.6 | Keshishyan et al. 2015 | ||||
Escherichia coli | Gram-negative bacteria | 451 | 500.0 | Hoenes et al. 2015 | ||||
Escherichia coli | Gram-negative bacteria | 455 | 219.3 | Lipovsky et al. 2010, Lui et al. 2016 | ||||
Escherichia coli | Gram-negative bacteria | 461 | 309.5 | Ghate et al. 2013, Ghate et al. 2015b | ||||
Escherichia coli | Gram-negative bacteria | 405–420 | 59–603 | 90–99.999% | Sabino et al. 2019, dos Anjos et al. 2020, dos Anjos et al. 2019, Halstead et al. 2019, Halstead et al. 2019, Plavskii et al. 2018, Leanse et al. 2018 | |||
feline calcivirus (ssRNA) | non-enveloped viruses | 405 | 82-719 | Tomb et al. 2016 | Riboflavin present in test*: yes and no | |||
feline infectious peritonitis virus (ssRNA, coronavirus) | lipid-enveloped viruses | 405 | 10.8-31.8 | Gardner et al. 2021 | Riboflavin present in test*: yes and no | |||
Fusarium oxysporum | Fungi | 405 | 540 | <90% | Leanse et al. 2021 | |||
Fusobacterium nucleatum | Gram-negative bacteria | 450 | 55.3 | Feuerstein et al. 2005 | ||||
Fusobacterium nucleatum, ss. Nucleatum | Gram-negative bacteria | 455 | 17.5 | Fontana et al. 2015 | ||||
Fusobacterium nucleatum, ss. polymorphum | Gram-negative bacteria | 455 | 4.0 | Fontana et al. 2015 | ||||
Fusobacterium nucleatum, ss. polymorphum | Gram-negative bacteria | 465 | 361.5 | Feuerstein, Persman and Weiss 2004 | ||||
Fusobacterium nucleatum, ss. vincenti | Gram-negative bacteria | 455 | 9.8 | Fontana et al. 2015 | ||||
Fusobacterium periodonticum | Gram-negative bacteria | 455 | 10.3 | Fontana et al. 2015 | ||||
HCoV-229E (ssRNA, coronavirus) | lipid-enveloped viruses | 405 | 55 | Enwemeka et al. 2021 | Riboflavin present in test*: yes | |||
HCoV-229E (ssRNA, coronavirus) | lipid-enveloped viruses | 405 pulsed | 89 | Lau et al. 2021 | Riboflavin present in test*: yes | |||
Helicobacter pylori | Gram-negative bacteria | 405 | 5.3 | Ganz et al. 2005, Hamblin et al. 2005 | ||||
herpes simplex virus Type 1 (dsDNA) | lipid-enveloped viruses | 445 | 112 | Zupin et al. 2018 | Riboflavin present in test*: unknown | |||
influenza A virus (ssRNA) | lipid-enveloped viruses | 405 | 23.5 | Rathnasinghe et al. 2021 | Riboflavin present in test*: unknown | |||
Klebsiella pneumoniae | Gram-negative bacteria | 400 | 74.8 | Halstead et al. 2016 | ||||
Klebsiella pneumoniae | Gram-negative bacteria | 405 | 46.2 | Maclean et al. 2009, Ramakrishnan et al. 2014, McDonald et al. 2013 | ||||
Klebsiella pneumoniae | Gram-negative bacteria | 410 | 108–1903 | 66.1–100% | dos Anjos et al. 2020, Shehatou et al. 2019, dos Anjos et al. 2020 | |||
Lactobacillus plantarum | Gram-positive bacteria | 405 | 374.0 | Kumar et al. 2016 | ||||
Lactobacillus plantarum | Gram-positive bacteria | 460 | 1121.0 | Kumar et al. 2016 | ||||
Legionella rubrilucens | Gram-negative bacteria | 450–470 | 300–500 | >99.999% | Schmid et al. 2019 | |||
Leuconostoc mesenteroides | Gram-positive bacteria | 470 | 257.1 | De Lucca et al. 2012 | ||||
Listeria ivanovii | Gram-positive bacteria | 405 | 44.9 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 400 | 117.4 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 405 | 45.9 | Endarko et al. 2012, Murdoch et al. 2012, McKenzie et al. 2014, Kumar et al. 2015 | ||||
Listeria monocytogenes | Gram-positive bacteria | 410 | 100.2 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 415 | 241.8 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 420 | 493.2 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 430 | 648.9 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 440 | 1120.9 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 450 | 3082.5 | Endarko et al. 2012 | ||||
Listeria monocytogenes | Gram-positive bacteria | 461 | 263.1 | Ghate et al. 2015b, Ghate et al. 2013 | ||||
Listeria monocytogenes | Gram-positive bacteria | 460–470 | 604.8 | >99.999% | Hyun et al. 2021 | |||
Listeria seeligeri | Gram-positive bacteria | 405 | 55.9 | Endarko et al. 2012 | ||||
MERS-CoV (ssRNA, coronavirus) | lipid-enveloped viruses | 425 | 18.8 | Stasko et al., 2021 | Riboflavin present in test*: yes | |||
Micrococcus sp. | Gram-positive bacteria | 405 | 24.9 | McDonald et al. 2013 | ||||
Moraxella catarrhalis | Gram-negative bacteria | 405 | 216 | 99.99% | Liu et al. 2020 | |||
murine leukaemia virus (ssRNA) | lipid-enveloped viruses | 420-430 | reduction | Richardson et al. 2005 | Riboflavin present in test*: yes | |||
murine norovirus | non-enveloped viruses | 408 (cw laser) | 491-1976 | Kingsley et al. 2018 | Riboflavin present in test*: yes | |||
Mycobacterium fortuitum | Gram-positive bacteria | 405–413 | 240–583.5 | 93–99.999% | Al-Shammary et al. 2020, dos Anjos et al. 2020 | |||
Mycobacterium smegmatis | Gram-positive bacteria | 405 | 67.8 | Guffey et al. 2013 | ||||
Mycobacterium terrae | Gram-positive bacteria | 405 | 57.6 | Murdoch et al. 2012 | ||||
Neisseria gonorrhoeae | Gram-negative bacteria | 405 | 45–108 | 99.99999% | Wang et al. 2017, Wang et al. 2019 | |||
phi 6 (dsRNA) | lipid-enveloped viruses | 405 | 400 | Vatter et al. 2021 | Riboflavin present in test*: no | |||
phi 6 (dsRNA) | lipid-enveloped viruses | 455 | 2130 | Vatter et al. 2021 | Riboflavin present in test*: no | |||
phi C31 (dsDNA) | non-enveloped viruses | 405 | 113-1021 | Tomb et al. 2014 | Riboflavin present in test*: yes and no | |||
Phi6 | Lipid-enveloped viruses | 405 | 1400 | 99.9% | Hessling et al. 2020 | |||
Porphyromonas gingivalis | Gram-negative bacteria | 405 | 40.5 | Hope et al. 2013 | ||||
Porphyromonas gingivalis | Gram-negative bacteria | 405 | 60 | 64.5% | Gelpi et al. 2015 | |||
Porphyromonas gingivalis | Gram-negative bacteria | 425 | 523.6 | Kim et al. 2013 | ||||
Porphyromonas gingivalis | Gram-negative bacteria | 450 | 47.0 | Feuerstein et al. 2005 | ||||
Porphyromonas gingivalis | Gram-negative bacteria | 455 | 48.8 | Fontana et al. 2015 | ||||
Porphyromonas gingivalis | Gram-negative bacteria | 465 | 94.0 | Feuerstein, Persman and Weiss 2004 | ||||
Prevotella intermedia | Gram-negative bacteria | 455 | 14.5 | Fontana et al. 2015 | ||||
Prevotella melaninogenica | Gram-negative bacteria | 455 | 7.2 | Fontana et al. 2015 | ||||
Prevotella nigrescens | Gram-negative bacteria | 455 | 9.8 | Fontana et al. 2015 | ||||
Propionibacterium acnes | Gram-positive bacteria | 405 | 13.3 | Hamblin et al. 2005 | ||||
Propionibacterium acnes | Gram-positive bacteria | 414 | 45.0 | Ashkenazi et al. 2003 | ||||
Propionibacterium acnes | Gram-positive bacteria | 450 pulsed | 20–45 | 100 % | Bumah et al. 2020, Bumah et al. 2020 | |||
Proteus vulgaris | Gram-negative bacteria | 405 | 30.6 | Maclean et al. 2009 | ||||
Prototheca Spp. | Algae | 410 | 137–320 | 99–99.0% | dos Anjos et al. 2019 | |||
Pseudomonas aeruginosa | Gram-negative bacteria | 400 | 17.8 | Halstead et al. 2016 | ||||
Pseudomonas aeruginosa | Gram-negative bacteria | 405 | 15.3 | Guffey and Wilborn 2006, Maclean et al. 2009, Kumar et al. 2015, Ramakrishnan et al. 2014, McDonald et al. 2013 | ||||
Pseudomonas aeruginosa | Gram-negative bacteria | 415 | 14.0 | Dai et al. 2013, Amin et al. 2016 | ||||
Pseudomonas aeruginosa | Gram-negative bacteria | 450 | 142.7 | Keshishyan et al. 2015 | ||||
Pseudomonas aeruginosa | Gram-negative bacteria | 470 | 69.1 | Guffey and Wilborn 2006, De Lucca et al. 2012, De Lucca et al. 2012 | ||||
Pseudomonas aeruginosa | Gram-negative bacteria | 470 | 603.44 | 65 % | Galo et al. 2022 | |||
Pseudomonas aeruginosa | Gram-negative bacteria | 405–415 | 10–463 | >90–100% | Al-Shammary et al. 2020, Sabino et al. 2019, dos Anjos et al. 2020, Fila et al. 2018, Leanse et al. 2018, Shehatou et al. 2019, Leanse et al. 2020 | |||
Pseudomonas fluorescens | Gram-negative bacteria | 400–420 | 99–420 | >99–100% | Angarano et al. 2020, Angarano et al. 2020, Hoenes et al. 2021 | |||
Pseudomonas fluorescens | Gram-negative bacteria | 450–470 | 500–604.8 | 90–99.9% | Hoenes et al. 2021, Hyun et al. 2021, Angarano et al. 2020 | |||
respiratory syncytial virus (ssRNA) | lipid-enveloped viruses | 420 | 29 | Terrosi et al. 2021 | Riboflavin present in test*: yes | |||
Saccharomyces cerevisiae | Yeasts | 405 | 182 | 90 % | Hoenes et al. 2018 | |||
Saccharomyces cerevisiae | Yeasts | 450 | 526 | 90 % | Hoenes et al. 2018 | |||
Salmonella ‘Heidelberg’ | Gram-negative bacteria | 470 | 138.4 | Bumah, Masson-Meyers and Enwemeka 2015b | ||||
Salmonella enterica | Gram-negative bacteria | 405 | 97.3 | Endarko et al. 2012, Murdoch et al. 2010, Murdoch et al. 2012 | ||||
Salmonella enteritidis | Gram-negative bacteria | 405 | 729 | >99.9999 | Keyvan et al. 2021 | |||
Salmonella Typhimurium | Gram-negative bacteria | 405 | 516.7 | Kumar et al. 2015 | ||||
Salmonella typhimurium | Gram-negative bacteria | 413 | 463.38 | 99.9% | dos Anjos et al. 2020 | |||
Salmonella Typhimurium | Gram-negative bacteria | 461 | 917.3 | Ghate et al. 2013, Ghate et al. 2015a | ||||
Salmonella Typhimurium | Gram-negative bacteria | 470 | 94.8 | Bumah, Masson-Meyers and Enwemeka 2015b | ||||
SARS-CoV-1 (ssRNA, coronavirus) | lipid-enveloped viruses | 425 | 9.9 | Stasko et al., 2021 | Riboflavin present in test*: yes | |||
SARS-CoV-2 | Lipid-enveloped viruses | 450–470 | 144 | >99% | Zupin et al. 2021 | |||
SARS-CoV-2 (ssRNA, coronavirus) | lipid-enveloped viruses | 420 | 29 | Terrosi et al. 2021 | Riboflavin present in test*: yes | |||
SARS-CoV-2 (ssRNA, coronavirus) | lipid-enveloped viruses | 425 | 5-18.8 | Stasko et al., 2021 | Riboflavin present in test*: yes | |||
SARS-CoV-2 (ssRNA, coronavirus) | lipid-enveloped viruses | 405 + blue/white | 6.6 | Biasin et al. 2021 | Riboflavin present in test*: yes | |||
SARS-CoV-2 (ssRNA, coronavirus) | lipid-enveloped viruses | 405 + blue/white | 7.5 | Rathnasinghe et al. 2021 | Riboflavin present in test*: unknown | |||
SARS-CoV-2 (ssRNA, coronavirus) | lipid-enveloped viruses | 410 + blue/white | 6.5 | de Santis et al. 2021 | Riboflavin present in test*: yes | |||
SARS-CoV-2 (ssRNA, coronavirus) | lipid-enveloped viruses | 450, 454, 470 | reduction | Zupin et al. 2021 | Riboflavin present in test*: unknown | |||
Serratia marcescens | Gram-negative bacteria | 405 | 169.6 | McDonald et al. 2013 | ||||
Shigella sonnei | Gram-negative bacteria | 405 | 89.5 | Endarko et al. 2012, Murdoch et al. 2012 | ||||
Staphylococcus aureus | Gram-positive bacteria | 400 | 16.5 | Halstead et al. 2016, Maclean et al. 2008b | ||||
Staphylococcus aureus | Gram-positive bacteria | 405 | 35.9 | Guffey and Wilborn 2006, Enwemeka et al. 2008, Maclean et al. 2009, Maclean et al. 2013, Kumar et al. 2016, Kumar et al. 2015, McKenzie et al. 2016, Maclean et al. 2008b | ||||
Staphylococcus aureus | Gram-positive bacteria | 410 | 21.4 | Maclean et al. 2008b | ||||
Staphylococcus aureus | Gram-positive bacteria | 415 | 84.1 | Maclean et al. 2008b, Lipovsky et al. 2010 | ||||
Staphylococcus aureus | Gram-positive bacteria | 420 | 78.3 | Maclean et al. 2008b | ||||
Staphylococcus aureus | Gram-positive bacteria | 425 | 929.0 | Kim et al. 2013 | ||||
Staphylococcus aureus | Gram-positive bacteria | 430 | 235.0 | Maclean et al. 2008b | ||||
Staphylococcus aureus | Gram-positive bacteria | 450 | 390.0 | Keshishyan et al. 2015 | ||||
Staphylococcus aureus | Gram-positive bacteria | 455 | 360.4 | Lipovsky et al. 2010 | ||||
Staphylococcus aureus | Gram-positive bacteria | 461 | 150.7 | Ghate et al. 2013 | ||||
Staphylococcus aureus | Gram-positive bacteria | 470 | 58.3 | Enwemeka et al. 2009, Guffey and Wilborn 2006, Bumah, Masson-Meyers and Enwemeka 2015b, Bumah et al. 2015a, Bumah et al. 2015a, Bumah, Masson-Meyers and Enwemeka 2015b, Bumah et al. 2013 | ||||
Staphylococcus aureus | Gram-positive bacteria | 470 | 603.44 | 80 % | Galo et al. 2020 | |||
Staphylococcus aureus | Gram-positive bacteria | 400–420 | 50–841 | 71–>99.999% | Al-Shammary et al. 2020, Sabino et al. 2019, dos Anjos et al. 2020, Lu et al. 2020, Maclean et al. 2020, Makdoumi et al. 2019, Wu et al. 2018, Rapacka-Zdonczyk et al. 2019, Leanse et al. 2020, Shehatou et al. 2019 | |||
Staphylococcus aureus | Gram-positive bacteria | 450 pulsed | 4.5–7.6 | 80–100% | Bumah et al. 2020 | |||
Staphylococcus carnosus | Gram-positive bacteria | 405–440 | 70–270 | 90–99.9% | Meurle et al. 2021, Hoenes et al. 2021 | |||
Staphylococcus carnosus | Gram-positive bacteria | 450–470 | 210–500 | 99–99.9% | Sicks et al. 2020, Hoenes et al. 2021 | |||
Staphylococcus epidermidis | Gram-positive bacteria | 405 | 50–122 | 99–99.999% | Lu et al. 2020, Shehatou et al. 2019 | |||
Staphylococcus epidermis | Gram-positive bacteria | 405 | 18.9 | Maclean et al. 2009, Ramakrishnan et al. 2016, Ramakrishnan et al. 2014, McDonald et al. 2013 | ||||
Stenotrophomonas maltophilia | Gram-negative bacteria | 400 | 15.0 | Halstead et al. 2016 | ||||
Streptococcus agalactiae | Gram-positive bacteria | 450 | pulsed 22.8 | 5.5–11% | Bumah et al. 2020 | |||
Streptococcus mutans | Gram-positive bacteria | 405 | 340–831 | 48–54% | Mohamad et al. 2021 | |||
Streptococcus pyogenes | Gram-positive bacteria | 405 | 10.8 | Maclean et al. 2009 | ||||
Streptococcus pyogenes | Gram-positive bacteria | 405 | 36–50 | 99.99–99.999999% | Lu et al. 2020, Shehatou et al. 2019 | |||
Trypanosoma cruzi | Protozoa | 405 | 270 | >99% | Jankowska et al. 2020 | |||
Tulane virus (ssRNA) | non-enveloped viruses | 405 | reduction | Kingsley et al. 2018 | Riboflavin present in test*: yes and no | |||
Vibrio parahaemolyticus | Gram-negative bacteria | 405 | 170.0 | Kumar et al. 2016 | ||||
Vibrio parahaemolyticus | Gram-negative bacteria | 460 | 717.0 | Kumar et al. 2016 | ||||
viral haemorrhagic septicaemia virus (ssRNA) | non-enveloped viruses | 405 | 114 | Ho et al. 2020 | Riboflavin present in test*: yes | |||
zika virus (ssRNA) | lipid-enveloped viruses | 445 | 64 | Zupin et al. 2018 | Riboflavin present in test*: unknown |
* Main review article number 3 (see below) discusses the presence of riboflavin in certain virus tests. A suspension containing riboflavin may contribute to the reduction of virus viability, as blue light can energize flavins and cause oxidation. The tests done with dry plates or suspensions not containing photo-sensitive compounds may therefore be more reliable.
Review articles used in compiling the list of microbe studies:
- Article group 1 (medium dosage / log level):
M. Hessling, B. Spellerberg, K. Hoenes.
Photoinactivation of bacteria by endogenous photosensitizers and exposure to visible light of different wavelengths – a review on existing data. FEMS Microbiology Letters, Volume 364, Issue 2, January 2017.
https://doi.org/10.1093/femsle/fnw270 - Article group 2 (used radiant exposure + achieved % reduction):
Leon G. Leanse, Carolina dos Anjos, Sana Mushtaq, Tianhong Dai.
Antimicrobial blue light: A ‘Magic Bullet’ for the 21st century and beyond' Advanced Drug Delivery Reviews 180 (2022) 114057
https://doi.org/10.1016/j.addr.2021.114057 - Article group 3 - viruses (90% reduction dose):
Martin Hessling, Bernhard Lau and Petra Vatter.
Review of Virus Inactivation by Visible Light
https://www.mdpi.com/2304-6732/9/2/113/pdf
Last updated October 2022.